Markets

Alnylam Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

(RTTNews) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):

-Earnings: -$219.48 million in Q2 vs. -$163.56 million in the same period last year. -EPS: -$2.02 in Q2 vs. -$1.63 in the same period last year. -Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$198.30 million or -$1.83 per share for the period. -Analysts projected -$1.86 per share -Revenue: $44.71 million in Q2 vs. $29.91 million in the same period last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ALNY